What are some of Geisinger’s priorities with Regeneron collaboration?

Geisinger Health System announced this week that it’s working with Regeneron Pharmaceuticals  (NASDAQ: REGN) in a project to use genetic samples from more than 100,000 volunteers to identify and validate associations between genes and human disease. The move reflects Geisinger’s efforts to advance genomic analysis from the research stage to the point where it is […]

Devices & Diagnostics

Diagnostic to predict risk of esophageal cancer raises $1.4 million

A molecular diagnostics company is raising fresh capital for a test to predict the likelihood of  a precancerous condition becoming esophageal cancer. The idea is that by detecting the condition earlier and more accurately, it could lead to better outcomes. Cernostics’ approach is called TissueCipher Pathology. It combines digital imaging pathology, fluorescence biomarkers, informatics and […]